Basilis Boutsinas

Prof. Dr. Basilis Boutsinas

Department of Business Administration, University of Patras, 26504 Rio, Greece
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2023 in Algorithms
Verified
Journal Article
Open access
PDF file
Antiopi PanteliAntiopi Panteli
Antiopi Panteli
BBBasilis Boutsinas
Basilis Boutsinas
Recommender systems aim to forecast users’ rank, interests, and preferences in specific products and recommend them to a user for purchase. Collaborative filtering is the most popular approach, where the user’s past purchase behavior consists of the user’s feedback. One of the most challenging problems in collaborative filtering is handling users whose previous item purchase behavior is unknown, (e.g., new users) or products for which user interactions are not available, (e.g., new products). In this work, we address the cold-start problem in recommender systems based on frequent patterns which are highly frequent in one set of users, but less frequent or infrequent in other sets of users. Such discriminant frequent patterns can distinguish one target set of users from all other sets. The proposed methodology, first forms different clusters of old users and then discovers discriminant frequent patterns for each different such cluster of users and finally exploits the latter to hallucinate the purchase behavior of new users. We also present empirical results to demonstrate the efficiency and accuracy of the proposed methodology.

26 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Evgenia GkintoniEvgenia Gkintoni
Evgenia Gkintoni
STEPHANOS P. VASSILOPOULOSSTEPHANOS P. VASSILOPOULOS
STEPHANOS P. VASSILOPOULOS
Georgios NikolaouGeorgios Nikolaou
Georgios Nikolaou
BBBasilis Boutsinas
Basilis Boutsinas
Background/Objectives: This systematic review explores the integration of digital and AI-enhanced cognitive behavioral therapy (CBT) for insomnia, focusing on underlying neurocognitive mechanisms and associated clinical outcomes. Insomnia significantly impairs cognitive functioning, overall health, and quality of life. Although traditional CBT has demonstrated efficacy, its scalability and ability to deliver individualized care remain limited. Emerging AI-driven interventions—including chatbots, mobile applications, and web-based platforms—present innovative avenues for delivering more accessible and personalized insomnia treatments. Methods: Following PRISMA guidelines, this review synthesized findings from 78 studies published between 2004 and 2024. A systematic search was conducted across PubMed, Scopus, Web of Science, and PsycINFO. Studies were included based on predefined criteria prioritizing randomized controlled trials (RCTs) and high-quality empirical research that evaluated AI-augmented CBT interventions targeting sleep disorders, particularly insomnia. Results: The findings suggest that digital and AI-enhanced CBT significantly improves sleep parameters, patient adherence, satisfaction, and the personalization of therapy in alignment with individual neurocognitive profiles. Moreover, these technologies address critical limitations of conventional CBT, notably those related to access and scalability. AI-based tools appear especially promising in optimizing treatment delivery and adapting interventions to cognitive-behavioral patterns. Conclusions: While AI-enhanced CBT demonstrates strong potential for advancing insomnia treatment through neurocognitive personalization and broader clinical accessibility, several challenges persist. These include uncertainties surrounding long-term efficacy, practical implementation barriers, and ethical considerations. Future large-scale longitudinal research is necessary to confirm the sustained neurocognitive and behavioral benefits of digital and AI-powered CBT for insomnia.

22 July 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
Evgenia GkintoniEvgenia Gkintoni
Evgenia Gkintoni
MPMaria Panagioti
Maria Panagioti
STEPHANOS P. VASSILOPOULOSSTEPHANOS P. VASSILOPOULOS
STEPHANOS P. VASSILOPOULOS
Georgios NikolaouGeorgios Nikolaou
Georgios Nikolaou
BBBasilis Boutsinas
Basilis Boutsinas
Apostolos VantarakisApostolos Vantarakis
Apostolos Vantarakis
Background: This systematic review examines artificial intelligence (AI) applications in neuroimaging for autism spectrum disorder (ASD), addressing six research questions regarding biomarker optimization, modality integration, social function prediction, developmental trajectories, clinical translation challenges, and multimodal data enhancement for earlier detection and improved outcomes. Methods: Following PRISMA guidelines, we conducted a comprehensive literature search across 8 databases, yielding 146 studies from an initial 1872 records. These studies were systematically analyzed to address key questions regarding AI neuroimaging approaches in ASD detection and prognosis. Results: Neuroimaging combined with AI algorithms demonstrated significant potential for early ASD detection, with electroencephalography (EEG) showing promise. Machine learning classifiers achieved high diagnostic accuracy (85–99%) using features derived from neural oscillatory patterns, connectivity measures, and signal complexity metrics. Studies of infant populations have identified the 9–12-month developmental window as critical for biomarker detection and the onset of behavioral symptoms. Multimodal approaches that integrate various imaging techniques have substantially enhanced predictive capabilities, while longitudinal analyses have shown potential for tracking developmental trajectories and treatment responses. Conclusions: AI-driven neuroimaging biomarkers represent a promising frontier in ASD research, potentially enabling the detection of symptoms before they manifest behaviorally and providing objective measures of intervention efficacy. While technical and methodological challenges remain, advancements in standardization, diverse sampling, and clinical validation could facilitate the translation of findings into practice, ultimately supporting earlier intervention during critical developmental periods and improving outcomes for individuals with ASD. Future research should prioritize large-scale validation studies and standardized protocols to realize the full potential of precision medicine in ASD.

1 July 2022 in EDULEARN Proceedings
Verified
Conference Paper
Closed access
PDF file
Evgenia GkintoniEvgenia Gkintoni
Evgenia Gkintoni
BBBasilis Boutsinas
Basilis Boutsinas
EKELIAS KOURKOUTAS
ELIAS KOURKOUTAS
Information about the paper titled "DEVELOPMENTAL TRAUMA AND NEUROCOGNITION IN YOUNG ADULTS: A SYSTEMATIC REVIEW" at IATED Digital Library

31 December 2008 in Pattern Recognition
Verified
Journal Article
Closed access
BBBasilis Boutsinas
Basilis Boutsinas
TPT. Papastergiou
T. Papastergiou

1 December 2008 in International Journal on Artificial Intelligence Tools
Verified
Journal Article
Closed access
BBBasilis Boutsinas
Basilis Boutsinas
CSCostas Siotos
Costas Siotos
AGAntonis Gerolimatos
Antonis Gerolimatos